Price: 2.9

Today's Change: -0.02

Today's Percent Change: 0%

Today's Volume: 481146

Average Daily Volume: 512134

52 week low: 1.5

52 week high: 3.6

Market cap: 160880000.0

EBITDA: -31810000.0

EBITDA / market_cap: -19.77%

Earnings per Share (EPS): 0.03

EPS / price: 1.03%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 0.47

Price to Book Ratio: 6.17

Price to Earnings (P/E) Ratio: 103.57

Price to Earnings Growth (PEG) Ratio: 0.98

Price to Sales (P/S) Ratio: 3.66

Short Ratio: 6.2

Exchange: "NCM"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 1.72

Resistance: 1.87

Pivot point: 1.78

SMA 10: 1.72

SMA 50: 1.85

SMA 100: 1.87

RSI 10: 56.85

RSI 50: 47.94

RSI 100: 47.96

EMA 10: 1.71

EMA 50: 1.88

EMA 100: 1.88

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

1.88

NEGATIVE

BDSI
BDSI

@PabloInvestobar: $TTNP any reason why management didn’t address the Nevada Correctional Facility opportunities on this past earnings… https://t.co/MqBhCPeAl4

@bulletin_en: Fosun International LTD Trimmed Biodelivery Sciences Intl In $BDSI Holding By $529,786; Us Bancorp De Lowered By $6… https://t.co/IiQY6RsGM4

@ZolmaxNews: BioDelivery Sciences International $BDSI Raised to “Buy” at Zacks Investment Research https://t.co/AaOsKPAvie

@bbnsnews: BioDelivery Sciences International $BDSI Cut to Sell at BidaskClub https://t.co/Wxzu0jwwaV

@bulletin_en: Cambrex Corporation $BDSI https://t.co/xeIt19Fyis

@bulletin_en: Contrasting of CytomX Therapeutics Inc. $BDSI https://t.co/U0wMzPiBp7

@ZolmaxNews: BioDelivery Sciences International $BDSI Rating Lowered to Sell at BidaskClub https://t.co/PbgV9J9NBQ

@TranscriptDaily: Zacks Investment Research Downgrades BioDelivery Sciences International $BDSI to Hold https://t.co/0J8rhviEPO